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Vascular calcification is prominent in end-stage renal disease. 14, 15 In contrast, histological findings of the atherosclerotic lesions at CKD stages III and IV or Apoe −/− mice after unilateral nephrectomy to a large extent resemble that of the lesions in normal kidney function. [8] [9] [10] Specific histopathologic features such as medial calcification that are observed in dialysis-dependent patients' arteries 14, 15 and severely uremic murine atherosclerosis models 8, 9, 13, 16 are not found. The mechanism of increased atherosclerosis in patients with mild-tomoderate renal impairment (RI) is incompletely understood.
Vascular wall infiltration by both innate and adaptive immune cells contributes to atherosclerotic lesion progression. 17 Alterations of the immune system by, for example, splenectomy, ablation of B cells, or specific T helper cell subsets can change the size and also the composition of atherosclerotic lesions, and alter collagen, lipid, or smooth muscle cell contents. 17, 18 Monocyte-derived myeloid cells that give rise to foam cell-forming macrophages and also fully functional antigenpresenting cells are central in plaque development. 17, 18 Their number within the arterial wall increases markedly during atherosclerosis development because of both immigration and local proliferation. Oxidized low-density lipoprotein (oxLDL) upregulates the expression of the β2 integrin subunit CD11c, a marker of antigen-presenting cells in mice, on monocytes. 19 CD11c-deficiency decreases atherosclerotic lesion size. 19 In atherosclerosis, CD11b + CD11c + cells are capable of both lipid phagocytosis and antigen presentation to CD4 + T cells. [20] [21] [22] [23] [24] This occurs in lymphatic organs; 21, 22 however, T cells are also located in close proximity to antigen-presenting cells in the atherosclerotic arteries of mice and humans 25, 26 and interact with each other in the vascular wall. 27 Close interaction with CD11b + CD11c + cells in the vascular wall was limited to Apoe −/− CD4 + T cells and did not occur with WT CD4 + T cells, suggesting an antigen-specific process. 27 The number of T lymphocytes increases during the atherosclerosis progression in the vessel. 17, 18 T cells are differentially regulated by myeloid and plasmacytoid dendritic cells 24 and can modulate atherosclerotic inflammation by cytotoxicity and cytokine secretion. While some T-cell cytokines such as interferon-γ have a proven proatherogenic role in diverse settings, 17, 18 the effect of others such as interleukin (IL)-17A is controversial. 28, 29 Enhancement of atherosclerotic lesion formation by IL-17A has been reported in some, [30] [31] [32] [33] [34] but not all, models. [35] [36] [37] [38] Although some studies were limited by available reagents, the role of IL-17A may also differ depending on the environment, for example, lesion localization 34, 35 or regulation of other immune mediators. 39 We found an induction of atherosclerosis by IL-17A in pharmacological immunosuppression 39 and also in IL-17A overproduction in the absence of the IL-27 receptor. 40 In patients with RI, some serum inflammatory markers are increased and correlate with mortality; among them is IL-6, which can enhance IL-17 production and can be induced by IL-17 itself. 41 Increased IL-17A in serum in a cohort of patients receiving hemodialysis for renal replacement was recently reported. 42 Cellular immune alterations in renal failure include, among others, peripheral blood lymphopenia and neutrophilia. 43 Circulating dendritic cells are depleted. 44 However, data from the atherosclerotic vascular wall are required for a better understanding of the inflammatory disease process. 45 Here, we examined the aortic leukocyte infiltrate in atherosclerotic Apoe −/− and LDL receptor-deficient (LDLr −/− ) mice with surgically induced impaired renal function (unilateral nephrectomy). Our initial screening revealed a significant increase in aortic leukocytes. We investigated myeloid cell phenotype, function, and mechanism of accumulation in RI.
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Methods
Detailed methods are available in the Online Data Supplement.
Animals
Wild-type (wt) C57Bl/6, LDLr −/− , Apoe −/− mice (both on C57Bl/6 background) (Jackson Labs, Bar Harbor, ME), CD11cYFP, kindly provided by Dr M. Nussenzweig, Rockfeller University, NY and crossed with Apoe −/− , and mice lacking IL-17A (Il17a −/− ), 96% C57Bl/6 background, kindly provided by Dr Y. Iwakura, University of Tokio, were genotyped by PCR and used in age-and sex-matched groups. Mice were kept in specific pathogen-free conditions. Animal experiments were approved by the Animal Care Committee at La Jolla Institute for Allergy and Immunology and Landesamt für Verbraucherschutz und Lebensmittelsicherheit, Lower Saxony, Germany. High-fat diet contained 40% kcal from fat and 1.5% cholesterol.
Bone Marrow Transplantation and Unilateral Nephrectomy
Experiments were commenced at 6 weeks of age. Bone marrow transplantations were performed as described. 46 Unilateral nephrectomy or decapsulation of the kidney were performed 1 week before high-fat diet was started.
Quantification of Atherosclerosis, Histological, and Aortic Leukocyte Analysis
Aortic en face staining and histological assessment of aortic roots, plasma lipid fast protein liquid chromatography, and measurement of GFR by FITC-Inulin are described in the Online Data Supplement. Preparation and flow cytometry of aortic leukocytes 39 and 2-photon imaging of aortic CD11c + /T-cell interaction were performed as described. 27 
Cell Culture Experiments
Cell culture procedures are described in the Online Data Supplement, and serum for stimulation experiments was obtained after written informed consent from patients with nondiabetic CKD described in the Online Data Supplement.
Statistical Analysis
Data are expressed as mean±SEM. Two-tailed Student t test and Mann-Whitney test were used to compare 2 conditions. One-way ANOVA and post hoc tests as indicated were used if >2 conditions were compared. P<0.05 was considered significant.
Results
Impaired Renal Function Increases Atherosclerotic Lesion Size and Aortic Leukocyte Infiltration
Unilateral nephrectomy significantly increased serum creatinine (Online Table I ) and decreased GFR measured by inulin clearance in Apoe −/− mice (Online Figure I ). This degree of RI significantly increased aortic atherosclerotic lesion size in Apoe −/− mice ( Figure 1A and 1B), with similar affection of both sexes (Online Figure IIA) . Aortic root lesion size also increased ( Figure 1C and 1D). Relative collagen contents C, Aortic flow cytometry after 12 weeks of high-fat diet showed increased CD11b + CD11c + and CD11c + cell numbers in RI (n=9-11; 4 independent experiments). D, Localization in established atherosclerotic lesions (12 weeks of high-fat diet) by confocal imaging revealed CD11c + (red) cells in the neointima. Most of these cells were also CD11b + (green) in both control and RI Apoe −/− mice. CD11b + CD11c + cells were present in foam cell (thick arrows; compare with lipid [ Figure 1D ]) and highly cellular regions. CD11b was also found in acellular intimal areas (arrowheads, compare with Figure 1D ; secondary antibodies only as negative control, ×40 original magnification). Ctrl indicates sham-operated control; L, lumen; and P, plaque. *P<0.05. and composition were essentially unaltered (Online Figure IIB and IIC). No significant differences in body or spleen weight occurred, and serum calcium, phosphorus, total leukocytes as a marker of systemic inflammation, thrombocyte, and erythrocyte counts were unaltered. Total serum cholesterol was increased, because of LDL, but not HDL levels (Online Table I ). No alteration was observed in renal leukocytes (data not shown).
In Apoe −/− mice with RI, significantly more leukocytes were recovered from the aorta by flow cytometry analysis as described 39 (Figure 1E ). All investigated leukocyte types, myeloid cells (CD11b + ), B cells (CD19 + ), and αβTCR + T cells were significantly more abundant ( Figure 1F and 1G) .
These data show that the increase in atherosclerotic lesion size in Apoe −/− mice with RI is accompanied by an extended inflammatory vascular infiltrate.
Enhanced Accumulation of Aortic Myeloid Cells and CD11c Expression in RI
We further investigated aortic accumulation of myeloid leukocytes in RI. Numbers of CD11b + myeloid cells in the aorta were significantly elevated already early in atherosclerosis development in Apoe −/− mice after 3 weeks of high-fat diet ( Figure 2A ). Aortic cell proliferation is highly elevated at this stage in mice with normal renal function. 20, 39 We labeled proliferating cells with BrdUrd and measured incorporation into CD11b + leukocytes. RI significantly increased proliferation of aortic myeloid leukocytes ( Figure 2B ). Expression of the antigen-presenting cell marker CD11c on aortic CD11b + myeloid cells 19, 20, 39 was enhanced in RI ( Figure 2A ).
Both myeloid cell numbers and the proportion that expressed CD11c had further increase in developed lesions after 12 weeks of high-fat diet ( Figure 2C ). Similar results were observed in male and female mice (Online Figure  III) . Cell localization in the vascular wall by confocal imaging showed large CD11c + and CD11b + neointimal areas ( Figure 2D ) in both lipid-rich and cellular plaque areas in the animals with RI.
RI Alters Myeloid Cell Function in the Atherosclerotic Aortic Wall
Next, we investigated lipid uptake and antigen-presenting function of myeloid aortic cells. Uptake of labeled exogenous oxLDL in aortic leukocytes was measured by flow cytometry ( Figure 3A ). Uptake into total CD11b + and the CD11b + CD11c + subgroup of aortic leukocytes was significantly lower in Apoe −/− mice with impaired renal function ( Figure 3B ).
We studied CD11c + cell/CD4 + T-cell movement and interactions in the aortic wall of mice with normal and impaired renal function. First, antigen presentation involves prolonged interactions with T cells and slowing of cell speed. We used a recently developed method 27 (Online Figure IV) to investigate this in the atherosclerotic aorta of mice with normal and impaired renal function. CD4 + T cells interacted with CD11c + cells in aortas of mice with RI for an increased proportion of the observation time (11±1% in control, 19±1% in RI; n=2; P=0.02). Second, productive T-cell interactions with antigen-presenting cells decrease the speed of both cell types. 47 The average speed of both CD11c + cells and CD4 + T cells was significantly lower in aortas from animals with RI than in controls (CD11c + in Figure 3C , Online Movies 1 and 2; CD4 + in Figure 3D , Online Movies 3 and 4). Third, T-cell stimulation by antigen-presenting cells induces proliferation. Aortic CD11b + CD11c + enhanced CD4 + T-cell proliferation during mixed lymphocyte reaction in vitro similar to spleen cells ( Figure 3E) . RI significantly increased proliferation of aortic αβTCR + lymphocytes but not CD19 + B lymphocytes ( Figure 3F ).
RI and IL-17A Alter Myeloid Cell Differentiation In Vitro
To test whether the altered aortic myeloid cell phenotype in mice with RI could be replicated in human cells, human adherent peripheral blood mononuclear cell cultures were supplemented with 10% serum from patients with mildly (CKD stages I and II, GFR>60 mL/min) and moderately (CKD stage III, GFR=30-60 mL/min) impaired renal function or healthy controls. Although lipid levels were elevated in both patient groups (Online Figure VA and VB) , uptake of oxLDL was decreased in cells cultured in CKD III but not in milder stages of CKD serum ( Figure 4A ). In contrast, human leukocyte antigen II (HLA-II) expression as marker of antigen-presenting cells was increased compared with healthy controls ( Figure 4B ).
We previously found that IL-17A enhanced accumulation of CD11b + CD11c + cells in peritonitis, 39 and we therefore tested whether IL-17A also upregulates HLA II as an antigen-presenting cell marker of human cells. HLA II expression was significantly higher if cells were exposed to IL-17A during macrophage culture ( Figure 4C ) and, more markedly, dendritic cell polarization by granulocyte-macrophage colony-stimulating factor and IL-4 ( Figure 4D) . Similarly, IL-17A supplementation during mouse myeloid-derived macrophage differentiation significantly increased CD11c expression ( Figure 4E ). The same result was found when IL-17A effects were tested in Il17a −/− and Il17ra −/− cells in parallel to correct for potential unspecific effects of recombinant IL-17A ( Figure 4F ). mRNA expression of genes implicated in cholesterol transport was assessed in Il17a −/− bone marrow-derived macrophages in the presence of IL-17A during differentiation ( Figure 4G ). Both CD36 and ABCA1 expressions were significantly decreased. oxLDL uptake by WT macrophages was dose-dependently decreased by IL-17A if cells were exposed during differentiation ( Figure 4H ).
IL-17A Expression in RI
Next, we assessed T-cell polarization in vivo. Among T-cell lineage markers, the T H17 transcription factor RORγt was Figure 5A ), and the proportion of splenic IL-17A producers was significantly increased ( Figure 5B and 5D). No significant change was seen in T-bet and interferonγ, markers of T H1 cells, and well-described proatherogenic mediators ( Figure 5A -5C) or Foxp3 + regulatory T cells with known antiatherogenic function ( Figure 5A and 5E). The increase in IL-17 production was not limited to CD4 + T cells; it also was observed in the CD4 − CD3 + compartment that includes multiple lineages (data not shown). 48 In serum from patients with impaired renal function (CKD stage III), many IL-17A measurements were below detection limits, similar to cohorts of patients with hypertension and the acute coronary syndrome. 49, 50 However, in 16 of 32 patients, but in only 3 of 9 of healthy volunteers, serum IL-17A was detectable (>6 pg/mL), and IL-17A effects on macrophage differentiation started at low concentrations ( Figure 4C and 4D) . Similarly, most other cytokine concentrations were below detection limits; however, there was a trend toward elevated tumor necrosis factor T H17 -related IL-6 levels (data not shown).
Recent data have shown that angiotensin induced increase in blood pressure, 49, 51 and tissue damage 52, 53 was mediated by IL-17A. Blockade of angiotensin signaling is among the most successful pharmacological interventions in RI. 54, 55 Angiotensin II serum concentration was increased in Apoe −/− mice with RI (135±47 pg/mL [RI] and 48±14 pg/mL [control]; n=6-7; P=0.02). We investigated the effect of angiotensin II on T-cell cytokines implicated in atherosclerosis development. No significant effect on interferon-γ production was observed, but angiotensin II significantly increased the number of IL-17A-producing T cells under T H17 polarizing conditions ( Figure 5F and 5G) . No effect on the proportion of IL-17A was observed if angiotensin II was applied either without T H17 favoring conditions (T H0 ; Figure 5F and 5G) or during restimulation of T cells (data not shown). The effect on T H17 polarization was reverted by the angiotensin receptor blocker Losartan ( Figure 5H ).
Increased Aortic Lesion Size and CD11b + CD11c + Leukocyte Accumulation in Impaired Renal Function Is IL-17A-Dependent
To directly investigate the role of IL-17A in atherosclerosis in RI, we reconstituted LDLr −/− mice with either WT or Il17a −/− bone marrow. Unilateral nephrectomy significantly decreased renal function as measured GFR in this mouse model of atherosclerosis (Online Figure I ). Online Table II shows that no significant differences occurred in body weight, circulating leukocytes and serum triglyceride, and total cholesterol levels. In RI, there was a tendency toward an increase in LDL and VLDL levels as determined by fast protein liquid chromatography (Online Figure VI) . Aortic lesion size was significantly increased in impaired renal function similar to the Apoe −/− atherosclerosis model (Figure 7A-7C) .
Reconstitution with Il17a −/− bone marrow abolished IL-17A-producing cells in the spleen (Online Figure VIIA) . Comparing control LDLr −/− mice that underwent transplantation with WT and Il17a −/− bone marrow, aortic root lesion size was similar. However, in the absence of IL-17A, RI no longer increased atherosclerotic lesion size ( Figure 6A was similar in all 4 experimental groups ( Figure 6C and 6D) , similar to what was observed in Apoe −/− mice (Online Figure  III) . However, lesional macrophage accumulation was significantly enhanced in RI in WT mice ( Figure 6E ). This was abolished in the absence of IL-17A.
RI increased CD11b and, more markedly, CD11c immunofluorescence staining in the aortic root of LDLr −/− mice with WT bone marrow ( Figure 7A ). This was abrogated in the absence of IL-17A. Also, by flow cytometry, significantly more CD11b + CD11c + leukocytes were detected in the aortas of WT LDLr −/− mice with RI compared with controls with normal renal function ( Figure 7B ). This increase was completely abolished in Il17a −/− -reconstituted LDLr −/− mice. Similar to the Apoe −/− model (Figure 2) , RI significantly increased aortic cell proliferation in control LDLr −/− mice ( Figure 7C and 7D) . The proliferation increase was also abolished in the absence of IL-17A. Collectively, these results suggest a central role for IL-17A in aggravation of atherosclerosis and vascular leukocyte accumulation in RI.
Discussion
Kidney disease is frequent and an independent risk factor for the development of atherosclerosis and its complications. The inflammatory response is increased but dysfunctional in patients receiving renal replacement therapy. 41, 56 However, inflammatory leukocytes within the vascular wall have not been systematically explored in patients receiving renal replacement therapy or with lesser degrees of RI. Our study shows a significant increase of total aortic leukocytes and CD11b + CD11c + myeloid cells in 2 independent murine atherosclerosis models, Apoe −/− and LDLr −/− mice, with a 50% decrease in renal glomerular number and significantly decreased GFR. Our study also identifies IL-17A as a critical mediator of atherosclerosis enhancement in RI.
The role of IL-17A in atherosclerosis in general is controversial. 28, 29 A proatherogenic role is suggested by antiatherogenic effects of IL-17-receptor blockade and IL-17A blockade in some, albeit not all, models 28, 29 and proatherogenic IL-17A effects in immunosuppressed Apoe −/− mice in which IL-17A participated in myeloid cell accumulation in the arterial wall. 39 The expressions of IL-17A and CD11b + myeloid cell accumulation in the aorta of mice with impaired kidney function were enhanced. Published data suggest that IL-17A can enhance antigen-presenting cell functions 30, 31 and macrophage cytokine secretion 57 in fully differentiated cells. In our in vitro model, IL-17A supplementation during differentiation significantly increased dendritic cell marker expression on mouse and human myeloid cells. It was demonstrated that CD11b + CD11c + cells can function as fully functional antigen-presenting cells within the aortic wall. 24, 27 We confirmed their ability to induce CD4 + T-cell proliferation. 24 We also demonstrate that RI not only enhanced accumulation of CD11b + CD11c + cells but also increased interactions with T cells. Productive interactions could locally promote T-cell cytotoxicity and cytokine production, further increasing atherosclerotic inflammation, including activation of other cell types such as smooth muscle cells and endothelium. In addition, activated lymphocytes and antigen-presenting cells migrating from the vascular wall to secondary and tertiary lymphatic organs 19, 22 could amplify systemic immune response.
Not only the recruitment but also the lipid scavenging function of aortic CD11b + CD11c + cells were significantly affected by RI. A previous report has described impaired efflux of cholesterol from peritoneal macrophages from mice with impaired renal function attributable to a decrease in ABCA1 gene expression. 58 The authors concluded that decreased cholesterol efflux would promote foam cell formation and thereby the enhancement of atherosclerosis in RI. We are able to expand this finding to the aorta in vivo. We also observed a decrease in lipid uptake in human macrophages exposed to serum from patients with CKD in vitro. Although multiple cytokines and other plasma components lipids may be differentially present in patients with RI, IL-17A by itself was sufficient for similar effects on human macrophages. IL-17A also decreased oxLDL uptake in murine bone marrow-derived macrophages. Both CD36 and ABCA1 cholesterol trafficking molecules gene expression was diminished by IL-17A. This change in lipid uptake may contribute to the altered lipid profile in Apoe −/− mice with RI as observed here and by others. 8, 9, 13, 16, 58 The changes in circulating lipid levels were significant in Apoe −/− , but not in LDLr −/− mice in our study. It is possible that the extreme lipid overload in Apoe −/− mice may make the changes in transport molecules more visible in systemic lipid levels. However, circulating lipid levels do not always correlate with disease severity. For example, in double ABCA1 −/− /ABCG1 −/− mice, a decrease in cholesterol efflux decreased macrophage lipid clearance abilities and increased atherosclerosis levels despite lower circulating lipid levels. 59 Also in impaired renal function, angiotensin II blockade was more antiatherogenic than a vasodilator despite higher cholesterol levels. 10 IL-17A influenced molecules responsible for both cholesterol influx and efflux and therefore may have local proatherogenic actions by increasing lipid deposition in the vascular wall, which are not necessarily reflected in plasma levels.
We found more IL-17A-producing T cells in Apoe −/− mice with decreased kidney function. IL-17A serum levels were also increased in a cohort of patients requiring hemodialysis. 42 Most importantly, RI had no effect on atherosclerotic lesion size and aortic CD11b + CD11c + leukocytes of LDLr −/− mice reconstituted with Il17a −/− bone marrow, suggesting a mechanistic role rather than an association of IL-17A in enhanced atherogenesis in RI. Several factors may confer atherosclerosis-promoting function to IL-17A in RI not observed under baseline conditions in LDLr −/− mice here or by others. 37 First, our results show enhancement of IL-17A production by angiotensin II under T H17 polarizing conditions. Angiotensin II blockade is a major disease-modifying factor in patients with kidney disease 54, 55 and more effective than blood pressure treatment with other agents in 5/6 51 and unilaterally nephrectomized mice. 10 Angiotensin II levels were elevated in mice with RI. The T H17regulating cytokine transforming growth factor-β was induced by angiotensin II in several forms of vascular inflammation. 60 Possibly, an enhancement by angiotensin II increases IL-17A levels enough to become a determinant of atherosclerosis severity. However, an amplification or alteration of the IL-17A signal in RI may also occur by other yet to be determined factors, for example, cytokines on IL-17A-responsive cells such as leukocytes.
In conclusion, our data show that RI increases atherosclerotic inflammation, alters aortic myeloid cell phenotype and their interaction with T lymphocytes, and suggests IL-17A as a key mediator for this increase in disease severity. 
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